Skip to content

VIC NEWS

From the blog

KenKotchPhoto-VIC-KSK6366

Matthew Murphy, recent graduate at Imperial College in London, spent the summer working in the lab at VIC.

VIC Labs DSC07234

High school senior Benjamin Shaer reflects on his summer in the VIC lab.

PHOTO-2023-08-01-18-40-10

Nanna Sivamanoharan is an MD student at the University of Edinburgh Medical School who spent the summer working in the lab at VIC.

IMG_2994

VIC Welcomes Summer Students for another Summer of Fruitful Research Work in the Lab

23023NewsUpdateimg

Recent FASEB publication from the VIC team presents a review on a potential comprehensive definition of a target product profile for optimizing islet cell transplantation for treating and potentially curing type 1 diabetes

B-cells-in-brain-injury---Twitter

Recent Publication in the Journal of Inflammation from Dr. Ruxandra Sîrbulescu

Sirbulescu-News-Post-61223

Congratulations to Dr. Ruxandra F. Sîrbulescu for her Promotion to Assistant Professor at Harvard Medical School

1-s2.0-S101113442300074X-gr3 (1)

Recent Research Publication from VIC’s Dr. Jeffrey Gelfand

Pandemic

We’re not ready for the next pandemic.

SNAP

Customizing T Cell-Based Immunotherapies in a ‘SNAP’

Hangry Too VIC News Post IMG

New Research Shows That Bacteria Get “Hangry,” Too

E.coli

A swapped genetic code prevents viral infections and gene transfer

Clare-VIC

James Adeosun is a student at Clare College of the University of Cambridge who spent the summer working in the lab at VIC.

Clare college

Celebrating the 20th Year of Annual Research Program at VIC for Clare College Students

FASEB SUSAN RAJU PAUL

FASEB Journal publication from VIC’s Dr. Susan Raju Paul

NYTIMES_Callahn

NY Times Opinion Piece from Dr. Michael Callahan:

VIC-Pub-11323

Bifunctional cancer cell–based vaccine concomitantly drives direct tumor killing and antitumor immunity

VIC Update 1223

Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo

DAVID_ALAGPULINSA

Keystone Symposium selects Dr. Alagpulinsa for 2023 Fellows Program

eOD-GT8-60mer-WEB

Novel HIV vaccine approach shows promise in first-in-human clinical trial

image

Dr. Poznansky Gives an Invited Research Talk about Latest Advances at VIC

Screen Shot 2022-11-09 at 1.21.39 PM

Investigating Cancer Immunotherapy Effects on COVID-19 Outcomes

new approaches to needleless vaccine delivery

New approaches to needle-less vaccine delivery

Screen Shot 2022-11-03 at 2.46.25 PM

A novel cuproptosis-related immune checkpoint gene signature identification and experimental validation in hepatocellular carcinoma

pHLIP-STING2

Cancer-seeking molecular delivery system could boost immunotherapy drug, research finds

VIC-polo-VII-2022-poster

VIC lab members enjoying social gatherings this summer.

DSC_1857VIC Update

Undergraduates enjoy a successful summer internship at VIC!

Cancer-Cell-Cover

Precise reconstruction of the TME using bulk RNA-seq and a machine learning algorithm trained on artificial transcriptomes.

unnamed

Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetti Immunity.

VIC-NEWs-WMIF-MGH

2022 WMIF | The Dr. Is In | Leveraging Novel Mechanisms for Vaccine and Immunotherapy Development

David-V-leaving-party-5-26-22

David Verrill Goodbye Event

image001

EpiVax and Massachusetts General Hospital Advance on T cell-Targeted Epitope Vaccine for Q Fever

image002

COVID Vaccines, Therapeutics, Variants, Long COVID, Ability To Tackle the Next Pandemic

Screen-Shot-2022-04-26-at-12.52.09-PM

A new platform for immunotherapeutic RNA delivery to cancer cells

Philanthropic support is critical to VIC’s success